Improving international access to EU-GMP certified products for the pharmaceutical industry.
Cannaport aims to solve the fundamental issues the industry is facing – lack of qualified products, quality and difficulty meeting regulatory standards.
Our goal is to ensure our clients can access any medicinal cannabis product their patients require, with their own brand. Simultaneously, we help suppliers grow – facilitating their access to new clients and markets.
Cannaport is present in Europe, North and South America.
Graduated in Pharmaceutical Sciences from the University of Coimbra, Pedro has vast experience in Pharmaco-vigilance and Clinical Trials monitoring, having worked at Infarmed I.P., and a pharmaceutical distributor where he assumed the role of technical director. Currently works at the European Medicines Agency.
Cannaport’s advisors provide great insight into patients and the market’s needs, and aid in driving the company in the right direction
Doctor of Radio-Oncology at the Portuguese Institute of Oncology (IPO) in Porto since 2015. He specializes in the treatment of chronic pain at a dedicated unit of the same institution, and has a postgraduate degree in Pain Medicine from the Faculty of Medicine, University of Porto. He is a member of the scientific board of the Portuguese Observatory of Medicinal Cannabis (OPCM) since its start.
With a strategic position in the market, Cannaport also offers consulting and brokerage services B2B to help your business grow
We help you develop your business through our deep expertise – in the field and in the market